Supernus Pharmaceuticals to Participate in March Investor Conferences

On February 23, 2026 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that management will participate in the following March investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 46th Annual Health Care Conference
Date:
Fireside chat:
Place:
Webcast Link:
Monday, March 2, 2026
2:30 p.m. ET
Boston Marriott Copley Place, Boston, Mass.
Here

Jefferies Biotech on the Beach Summit
Date:
Place: Tuesday, March 10, 2026
1 Hotel South Beach, Miami Beach, Fla.

Barclays 28th Annual Global Healthcare Conference
Date:
Fireside chat:
Place:
Webcast Link: Wednesday, March 11, 2026
2:00 p.m. ET
Loews Miami Beach, Miami Beach, Fla.
Here

Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinators.

A live audio webcast of the TD Cowen and Barclays Conference presentations can also be accessed on the Events & Presentations section of the Supernus Pharmaceuticals website at www.supernus.com. Archived replays of these webcasts will be available for 60 days on the Company’s website following the conference.

(Press release, Supernus, FEB 23, 2026, View Source [SID1234662862])